{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:22:10Z","timestamp":1756570930472},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Taiwan Society of Pediatric Cardiology","award":["TSPC-201401"],"award-info":[{"award-number":["TSPC-201401"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jpeds.2017.11.044","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T20:44:48Z","timestamp":1517517888000},"page":"108-114.e1","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Efficacy of a Novel Palivizumab Prophylaxis Protocol for Respiratory Syncytial Virus Infection in Congenital Heart Disease: A Multicenter Study"],"prefix":"10.1016","volume":"195","author":[{"given":"Shuenn-Nan","family":"Chiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieh-Neng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Ching","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Tao","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Yin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Hwan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chuan","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Tai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jou-Kou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2017.11.044_bib0010","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s10096-011-1529-y","article-title":"Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis","volume":"31","author":"Hervas","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1067\/mpd.2000.110531","article-title":"Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid","volume":"137","author":"Boyce","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1651-2227.2002.tb03282.x","article-title":"Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting","volume":"91","author":"Eriksson","year":"2002","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0025","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","author":"Feltes","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1651-2227.2010.02059.x","article-title":"Meta-analysis of passive immunoprophylaxis in paediatric patients at risk of severe RSV infection","volume":"100","author":"Pons","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0035","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jpeds.2009.11.062","article-title":"Prevalence of congenital heart disease at live birth in Taiwan","volume":"156","author":"Wu","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0040","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1542\/peds.2004-0224","article-title":"Economic analysis of palivizumab in infants with congenital heart disease","volume":"114","author":"Yount","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0045","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1542\/peds.2009-2345","article-title":"From the American Academy of Pediatrics: policy statements\u2013modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections","volume":"124","author":"Committee on Infectious Diseases","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpeds.2015.12.029","article-title":"Risk of respiratory syncytial virus infection in cyanotic congenital heart disease in a subtropical area","volume":"171","author":"Chiu","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0060","series-title":"Recommendations for Prevention of RSV Infection in Taiwan","first-page":"19","article-title":"Recommendations for palivizumab vaccination","year":"2015"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0065","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/ndt\/gfv071","article-title":"Analyzing hospitalization data: potential limitations of Poisson regression","volume":"30","author":"Weaver","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0070","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","article-title":"Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus","volume":"176","author":"Johnson","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0075","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.inf.0000133165.85909.08","article-title":"Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection","volume":"23","author":"Saez-Llorens","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0080","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1542\/peds.2004-1300","article-title":"Annual variation in respiratory syncytial virus season and decisions regarding immunoprophylaxis with palivizumab","volume":"114","author":"Meissner","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0085","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.inf.0000053882.70365.c9","article-title":"Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus","volume":"22","author":"Stensballe","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0090","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1086\/315508","article-title":"Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America","volume":"181","author":"Peret","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100981","article-title":"A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan","volume":"9","author":"Chi","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110166","article-title":"Prolonged seasonality of respiratory syncytial virus infection among preterm infants in a subtropical climate","volume":"9","author":"Hsu","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0105","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1128\/JCM.29.11.2614-2615.1991","article-title":"Respiratory syncytial virus infection and prevalence of subgroups A and B in Hawaii","volume":"29","author":"Reese","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00246-007-9039-5","article-title":"Palivizumab use in subjects with congenital heart disease: results from the 2000-2004 Palivizumab Outcomes Registry","volume":"29","author":"Cohen","year":"2008","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0115","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/S0140-6736(12)60107-X","article-title":"Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis","volume":"379","author":"Thangaratinam","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1542\/peds.2009-1397","article-title":"Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP","volume":"124","author":"Mahle","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0125","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/archpediatrics.2010.298","article-title":"Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications","volume":"165","author":"Hampp","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jpeds.2017.11.044_bib0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/11531860-000000000-00000","article-title":"Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic review","volume":"28","author":"Prescott","year":"2010","journal-title":"Pharmacoeconomics"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347617316001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347617316001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T23:50:18Z","timestamp":1603756218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347617316001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":25,"alternative-id":["S0022347617316001"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2017.11.044","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a Novel Palivizumab Prophylaxis Protocol for Respiratory Syncytial Virus Infection in Congenital Heart Disease: A Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2017.11.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}